首頁 › 糖尿病 › 阿拉巴馬州 › Birmingham
Birmingham, AL 的 糖尿病 臨床試驗
9 項針對 糖尿病 的研究正在 Birmingham（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
招募中3 期
- Univ of Alabama Birmingham, Birmingham
Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)
招募中
- UAB Highlands Hospital/Department of Family and Community Medicine, Birmingham
Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
招募中觀察性研究
- Cooper Green Mercy Hospital, Birmingham
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
招募中2 期歡迎健康志工
- University of Alabama at Birmingham, Birmingham
Empowering Faith-based Communities to Provide Personalized Diabetes Self-management Education and Support (DSMES) in the Magic City
招募中歡迎健康志工
- New Hope Baptist Church, Birmingham
CGM for Management of Type 2 Diabetes in Pregnancy
招募中
- University of Alabama at Birmingham, Birmingham
CARBON: UAB Cardiovascular Research Biobank
招募中觀察性研究歡迎健康志工
- University of Alabama at Birmingham, Birmingham
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
招募中觀察性研究
- University of Alabama at Birmingham, Birmingham
Inspire HER: Inspiring the Heart and Emotions for Radical Health
招募中
- University of Alabama at Birmingham, Birmingham
其他城市的 糖尿病 試驗
- Boston, MA23 項研究
- New York City, NY17 項研究
- Houston, TX16 項研究
- Chicago, IL15 項研究
- Durham, NC14 項研究
- Aurora, CO14 項研究
- Baltimore, MD13 項研究
- Philadelphia, PA12 項研究
- San Diego, CA10 項研究
- Los Angeles, CA10 項研究
- Indianapolis, IN10 項研究
- Washington, DC10 項研究
Birmingham 的其他研究
- 癌症（所有類型）31 項研究
- 乳癌24 項研究
- 卵巢癌23 項研究
- 肥胖症23 項研究
- 非小細胞肺癌22 項研究
- 急性髓系白血病21 項研究
- 多發性骨髓瘤18 項研究
- 慢性阻塞性肺病17 項研究
- 心血管疾病17 項研究
- 第二型糖尿病16 項研究
- 子宮內膜癌16 項研究
- 過重16 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。